October 30, 2015 | At Direct Genomics in Shenzhen, He Jiankui has built what he hopes will be China's second homegrown gene sequencer approved for clinical use, with three hospital partnerships and early panels in cancer, Hepatitis B, and prenatal screening. His technology is adopted from the defunct Helicos Biosciences of Cambridge, Mass., whose sequencers never caught on with researchers — but have some promising characteristics as diagnostic instruments.
Read the whole story at Bio-IT World.